XTX Topco’s NovoCure NVCR Stock Holding History

XTX Topco’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$361K	Buy	+23,796	New	+$360K	﹤0.01%	2747
2026 Q1	–	Sell	-58,795	Closed	-$760K	–	4201
2025 Q4	$760K	Buy	58,795 +36,111	+159%	+$464K	0.02%	1243
2025 Q3	$293K	Buy	+22,684	New	+$303K	0.02%	1521
2025 Q1	–	Sell	-14,395	Closed	-$429K	–	2877
2024 Q4	$429K	Buy	+14,395	New	+$305K	0.04%	901
2024 Q3	–	Sell	-18,407	Closed	-$315K	–	2441
2024 Q2	$315K	Sell	18,407 -14,602	-44%	-$257K	0.03%	922
2024 Q1	$516K	Sell	33,009 -13,967	-30%	-$205K	0.07%	470
2023 Q4	$701K	Buy	46,976 +14,985	+47%	+$201K	0.15%	105
2023 Q3	$517K	Buy	+31,991	New	+$922K	0.09%	384
2023 Q2	–	Sell	-3,995	Closed	-$240K	–	1707
2023 Q1	$240K	Buy	+3,995	New	+$319K	0.05%	816
2022 Q1	–	Sell	-3,172	Closed	-$238K	–	876
2021 Q4	$238K	Buy	3,172 +1,320	+71%	+$132K	0.13%	297
2021 Q3	$215K	Buy	+1,852	New	+$280K	0.07%	474
2021 Q2	–	Sell	-3,141	Closed	-$415K	–	1007
2021 Q1	$415K	Buy	+3,141	New	+$497K	0.2%	151

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

XTX Topco's NVCR Position: Q2 2026 in Review

XTX Topco opened a new position in NovoCure (NVCR) in Q2 2026: 23,796 shares worth $361K. The stake represents ﹤0.01% of the portfolio and ranks #2747 among its holdings. This is a return to the name: XTX Topco previously reported a position in NVCR as recently as Q4 2025.

XTX Topco first reported a position in NVCR in Q1 2021 and has held it in 12 quarters since. The position peaked at $760K in Q4 2025. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

XTX Topco held 23,796 shares of NovoCure worth $361K as of Q2 2026.
NovoCure was a new XTX Topco position in Q2 2026.
NovoCure made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #2747 holding.
XTX Topco first reported a position in NovoCure in Q1 2021 and has held it in 12 quarters since.
XTX Topco's NovoCure position peaked at $760K in Q4 2025.
218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.